Imagine that, using your smartphone, you log into a Zoom call from home. You connect with your MS specialist and, while you're chatting, an artificial intelligence-based system is analyzing biometric measurements that will enable your doctor to deliver or fine-tune an MS treatment plan that's been personalized to meet your exact needs.
That's the vision driving NeuraLight, an early-stage company that's, first, aiming to re-write clinical trial design and accelerate new drug development. Joining me to give us an exclusive briefing on NeuraLight's game-changing mission is the co-founder and CEO of NeuraLight, Micha Breakstone.
We're also sharing the results of a pilot study that looked at the impact of intermittent fasting on people living with MS.
We'll tell you about a study that explored how social support affected the quality of sleep among people living with MS during the COVID-19 pandemic.
We've talked a lot about neurofilament light chain in past episodes of RealTalk MS. In this episode, we'll tell you about Labcorp's 2,000 patient service centers that now offer a blood test to measure neurofilament light chain levels. (And we'll tell you why that's a very good thing!)
We'll also share the results of a study that shows how experts may be underestimating the economic burden of living with MS in Canada.
And if you think you might be interested in participating in a study designed to measure the impact of different diets on MS, we'll give you the details about how you can get involved.
We have a lot to talk about! Are you ready for RealTalk MS??!
NeuraLight's vision of the future :22
Intermittent fasting produces immune and metabolic changes in people with MS 1:28
Study shows social support is a predictor of sleep quality in people with MS during the COVID-19 pandemic 4:30
Labcorp announces availability of neurofilament light chain blood test 6:39
CanProCo research shows the economic burden of living with MS in Canada may be underestimated 8:58
Dr. Terry Wahls is recruiting for a study of how 3 different diets impact MS 12:16
Micha Breakstone gives us an exclusive briefing about how NeuraLight may change everything (for the better!) when it comes to MS drug development and MS care 15:28
Share this episode 34:17
Download the RealTalk MS app for your iOS or Android device 34:38
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/256
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
National MS Society COVID-19 Vaccine Guidance for People Living with MS
STUDY: Intermittent Calorie Restriction Alters T-Cell Subsets and Metabolic Markers in People with Multiple Sclerosis
STUDY: Social Support Predicts Sleep Quality in People with Multiple Sclerosis During the COVID-19 Pandemic
STUDY: Productivity Loss Among People with Early Multiple Sclerosis: A Canadian Study
Screening Survey for Efficacy of Diet on Quality of Life in Multiple Sclerosis Study
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS Devices
Download the RealTalk MS App for Android Devices
Give RealTalk MS a rating and review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 256
Guest: Micha Breakstone
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS